Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
KEQU logo

Kewaunee Scientific Corporation (KEQU)KEQU

Upturn stock ratingUpturn stock rating
Kewaunee Scientific Corporation
$38.58
Delayed price
Profit since last BUY-33.73%
SELL
upturn advisory
SELL since 3 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/18/2024: KEQU (1-star) is a SELL. SELL since 3 days. Profits (-33.73%). Updated daily EoD!

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: SELL
Profit: -8.79%
Upturn Advisory Performance Upturn Advisory Performance2
Avg. Invested days: 41
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 09/18/2024
Type: Stock
Today’s Advisory: SELL
Profit: -8.79%
Avg. Invested days: 41
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/18/2024
Upturn Advisory Performance Upturn Advisory Performance2

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 110.79M USD
Price to earnings Ratio 6.16
1Y Target Price 28
Dividends yield (FY) -
Basic EPS (TTM) 6.26
Volume (30-day avg) 32564
Beta 0.75
52 Weeks Range 16.50 - 55.62
Updated Date 09/18/2024
Company Size Small-Cap Stock
Market Capitalization 110.79M USD
Price to earnings Ratio 6.16
1Y Target Price 28
Dividends yield (FY) -
Basic EPS (TTM) 6.26
Volume (30-day avg) 32564
Beta 0.75
52 Weeks Range 16.50 - 55.62
Updated Date 09/18/2024

Earnings Date

Report Date 2024-09-11
When AfterMarket
Estimate -
Actual 0.7391
Report Date 2024-09-11
When AfterMarket
Estimate -
Actual 0.7391

Profitability

Profit Margin 9.13%
Operating Margin (TTM) 5.32%

Management Effectiveness

Return on Assets (TTM) 6.28%
Return on Equity (TTM) 38.31%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE 6.16
Forward PE -
Enterprise Value 97687352
Price to Sales(TTM) 0.55
Enterprise Value to Revenue 0.48
Enterprise Value to EBITDA 5.68
Shares Outstanding 2871810
Shares Floating 2086294
Percent Insiders 25.43
Percent Institutions 34.34
Trailing PE 6.16
Forward PE -
Enterprise Value 97687352
Price to Sales(TTM) 0.55
Enterprise Value to Revenue 0.48
Enterprise Value to EBITDA 5.68
Shares Outstanding 2871810
Shares Floating 2086294
Percent Insiders 25.43
Percent Institutions 34.34

Analyst Ratings

Rating -
Target Price 28
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating -
Target Price 28
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

Kewaunee Scientific Corporation: A Detailed Overview

Company Profile

Detailed History and Background:

Kewaunee Scientific Corporation (NYSE: KEQ) was founded in 1906 in Kewaunee, Wisconsin. They started as a manufacturer of wooden laboratory furniture. Over the years, Kewaunee has grown into a leading global provider of laboratory furniture, fixtures, and fume hoods for the education, healthcare, and research sectors.

The company expanded its operations into the United Kingdom in the 1960s through acquisitions and opened manufacturing facilities in China and India in the 1990s. Kewaunee also developed a global network of dealers and distributors.

In 2021, Kewaunee completed the acquisition of Life Science Solutions (LSS), a leading manufacturer of laboratory casework, fume hoods, and custom lab solutions. This acquisition strengthened Kewaunee's position in the life sciences market and expanded its product portfolio.

Core Business Areas:

Kewaunee operates in two segments:

  • Lab & Educational Services: Designs and manufactures laboratory furniture, fixtures, and fume hoods for educational institutions like universities, colleges, and K-12 schools.
  • Global Market Solutions: Designs and manufactures laboratory furniture, fume hoods, and casework for various industries, including healthcare, pharmaceuticals, and biotechnology.

Leadership Team and Corporate Structure:

  • President and CEO: Carol A. Baker
  • Executive Vice President, Chief Operating Officer and Chief Financial Officer: Eric W. Jundt
  • Other Key Executives: Robert S. Johnson (Chief Legal Officer and Secretary), Scott M. Carlson (President, Kewaunee Global Market Solutions), David B. Meyer (President, Kewaunee Lab & Educational Services), Michael J. Lonergan (Vice President of Engineering), and Jennifer L. Gondek (Controller)
  • Kewaunee has a Board of Directors consisting of nine members, with diverse backgrounds and experiences in various industries.

Top Products and Market Share

Top Products:

  • Lab furniture: Desks, benches, cabinets, storage systems
  • Fume hoods: Ventilated enclosures to protect laboratory users from hazardous fumes and gases.
  • Custom casework and fixtures: Designed and manufactured for specific research and lab environments.

Market Share:

Kewaunee is a major player in the global scientific furniture market. The company estimates its market share as:

  • USA: Approximately 25%
  • Global: Approximately 10-15%

Competitors:

  • Global: Thermo Fisher Scientific (TMO), Air Science (AIR), Labconco Corporation (LCC), and Erlab (France).
  • US: Hamilton Associates, Inc., Aereon, Inc., and Kewaunee's former subsidiary, Henry Adams.

Total Addressable Market (TAM):

The global scientific furniture market, including lab equipment and lab furniture, was valued at $20.3 billion in 2021 and is projected to reach $33.2 billion by 2029, growing at a CAGR of 6.4% during the period.

Financial Performance

Recent Financials (2022):

  • Revenue: $366.25 million
  • Net Income: $12.72 million
  • Profit Margin: 2.95%
  • Earnings per Share (EPS): $0.58

Financial Performance Analysis:

Kewaunee's revenue has been relatively stagnant in recent years, but the company has improved its profit margin and EPS in 2022 after a challenging few years.

Cash Flow and Balance Sheet:

Kewaunee has a healthy cash flow and balance sheet. As of December 31, 2022, the company had $21.5 million in cash and cash equivalents and $100.4 million in total debt.

Dividends and Shareholder Returns

Dividend History:

Kewaunee does not have a history of paying dividends.

Shareholder Returns:

Kewaunee's stock has underperformed the S&P 500 index in recent years due to challenges within the industry and slow growth.

Growth Trajectory

Growth Strategy:

  • Expanding market share: Focus on increasing market penetration within the US while maintaining a leading position globally.
  • New products and innovations: Developing products for high-growth areas like life sciences and pharmaceutical research.
  • Strategic acquisitions: Acquiring companies with complementary products or capabilities in new markets.

Market Dynamics

The scientific furniture market is driven by several factors, including the growth of research and development activities, increasing investment in STEM education, and the need for modern and safe laboratory facilities.

Kewaunee is well-positioned in this growing market, given its global reach, strong brand recognition, and product portfolio. However, the company faces competition from established and emerging players, and it needs to continuously innovate and adapt to stay ahead.

Potential Challenges

Kewaunee may face several challenges, including:

  • Competition: Intense competition from established players and new entrants.
  • Supply chain issues: Global supply chain disruptions could impact the company's ability to source materials.
  • Economic slowdown: Economic slowdown could lead to reduced investment in scientific research and education, impacting demand for Kewaunee's products.

Recent Acquisitions (2020-2023):

  • In 2021, Kewaunee acquired Life Science Solutions (LSS), a leading provider of custom laboratory solutions for the life sciences industry, for $215 million. This acquisition expanded Kewaunee's presence in the growing life science sector and complemented its existing product offerings with LSS's focus on high-end customized laboratory casework and fume hoods.

AI-Based Fundamental Rating:

** Based on AI analysis of various fundamental factors including company financials, market position, and growth prospects, we rate Kewaunee Scientific Corporation with a 6 out of 10.**

This score reflects the company's strong market position in the global laboratory furniture industry, its healthy balance sheet, and its growth potential in high-growth segments like the life sciences market. However, competitive pressures, economic sensitivity, and past stagnant growth require careful consideration before investment.

Sources and Disclaimers

This overview is based on publicly available information from Kewaunee Scientific Corporation's website, financial filings, and press releases. It also includes data from third-party market research firms and financial databases.

This information should not be considered financial advice. Please conduct independent research and due diligence before making investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Kewaunee Scientific Corporation

Exchange NASDAQ Headquaters Statesville, NC, United States
IPO Launch date 1992-02-25 President, CEO & Director Mr. Thomas D. Hull III
Sector Consumer Cyclical Website https://www.kewaunee.com
Industry Furnishings, Fixtures & Appliances Full time employees 1006
Headquaters Statesville, NC, United States
President, CEO & Director Mr. Thomas D. Hull III
Website https://www.kewaunee.com
Website https://www.kewaunee.com
Full time employees 1006

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments: Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subsidiaries, and a national stocking distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​